Literature DB >> 26227251

From Mesoderm to Mesodermatology: Bone Marrow Mesenchymal Cells Heal Skin Wounds.

Marketa Tolarova1, Jakub Tolar2.   

Abstract

Mesh：

Year:  2015        PMID： 26227251      PMCID： PMC4817871          DOI： 10.1038/mt.2015.84

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  18 in total

1.  Fibroblast cell therapy enhances initial healing in recessive dystrophic epidermolysis bullosa wounds: results of a randomized, vehicle-controlled trial.

Authors:  G Petrof; M Martinez-Queipo; J E Mellerio; P Kemp; J A McGrath
Journal:  Br J Dermatol       Date:  2013-11       Impact factor: 9.302

2.  Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity.

Authors:  Johannes S Kern; Stefan Loeckermann; Anja Fritsch; Ingrid Hausser; Wera Roth; Thomas M Magin; Claudia Mack; Marcel L Müller; Oliver Paul; Patrick Ruther; Leena Bruckner-Tuderman
Journal:  Mol Ther       Date:  2009-06-30       Impact factor: 11.454

3.  A biologic Velcro patch.

Authors:  Jakub Tolar; John E Wagner
Journal:  N Engl J Med       Date:  2015-01-22       Impact factor: 91.245

4.  Bone marrow transplantation for recessive dystrophic epidermolysis bullosa.

Authors:  John E Wagner; Akemi Ishida-Yamamoto; John A McGrath; Maria Hordinsky; Douglas R Keene; David T Woodley; Mei Chen; Megan J Riddle; Mark J Osborn; Troy Lund; Michelle Dolan; Bruce R Blazar; Jakub Tolar
Journal:  N Engl J Med       Date:  2010-08-12       Impact factor: 91.245

5.  The relationship between the spleen colony-forming cell and the haemopoietic stem cell.

Authors:  R Schofield
Journal:  Blood Cells       Date:  1978

6.  Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa.

Authors:  Paulette Conget; Fernando Rodriguez; Susanne Kramer; Carolina Allers; Valeska Simon; Francis Palisson; Sergio Gonzalez; Maria J Yubero
Journal:  Cytotherapy       Date:  2010-05       Impact factor: 5.414

7.  PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia.

Authors:  Katsuto Tamai; Takehiko Yamazaki; Takenao Chino; Masaru Ishii; Satoru Otsuru; Yasushi Kikuchi; Shin Iinuma; Kotaro Saga; Keisuke Nimura; Takashi Shimbo; Noriko Umegaki; Ichiro Katayama; Jun-ichi Miyazaki; Junji Takeda; John A McGrath; Jouni Uitto; Yasufumi Kaneda
Journal:  Proc Natl Acad Sci U S A       Date:  2011-04-04       Impact factor: 11.205

8.  Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells.

Authors:  Jakub Tolar; Akemi Ishida-Yamamoto; Megan Riddle; Ron T McElmurry; Mark Osborn; Lily Xia; Troy Lund; Catherine Slattery; Jouni Uitto; Angela M Christiano; John E Wagner; Bruce R Blazar
Journal:  Blood       Date:  2008-10-27       Impact factor: 22.113

9.  Potential of fibroblast cell therapy for recessive dystrophic epidermolysis bullosa.

Authors:  Tracy Wong; Luke Gammon; Lu Liu; Jemima E Mellerio; Patricia J C Dopping-Hepenstal; John Pacy; George Elia; Rosemary Jeffery; Irene M Leigh; Harshad Navsaria; John A McGrath
Journal:  J Invest Dermatol       Date:  2008-04-03       Impact factor: 8.551

10.  Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance.

Authors:  Takenao Chino; Katsuto Tamai; Takehiko Yamazaki; Satoru Otsuru; Yasushi Kikuchi; Keisuke Nimura; Masayuki Endo; Miki Nagai; Jouni Uitto; Yasuo Kitajima; Yasufumi Kaneda
Journal:  Am J Pathol       Date:  2008-08-07       Impact factor: 4.307
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.